Quave Lab Schedule at ASM Microbe Conference

Quave Lab is presenting at ASM Microbe – come see us! Saturday, 6/9/18, 11am-1pm in building B poster hall: Jubilee Park presenting her work on resistance modifying agents for Acinetobacter baumannii at Poster 787 Sunday, 6/10/18, 12:45-1:30 pm in the Exhibit and Poster hall, Building B – 369. Dr. Quave…

Continue reading

New Antibiotic Discovery Project Funded

I’m excited to announce that our project “Novel compounds from botanical innovation yields Acinetobacter treatments” was selected for funding via the R21 mechanism at NIH/NIAID. This is a collaborative project to be undertaken together between the Quave Research Group at Emory University, with co-investigator Dr. Julia Kubanek’s group at Georgia…

Continue reading

More press links on paper showing how Sweet Chestnut disarms MRSA

We are so excited to have had press coverage on our most recent collaborative paper with the Horswill group! Stay tuned to our Twitter feed (@QuaveEthnobot) for news on the discovery. The full original article is available free via Open Access at PLoS ONE. Here are some links to the…

Continue reading

New paper reviews state-of-the-art tools for anti-virulence drug discovery in staph!

Flipping the switch: tools for detecting small molecule inhibitors of staphylococcal virulence Drs. Quave and Horswill have co-authored a review on different laboratory tools and approaches that can be used to detect small molecule inhibitors of Staphylococcus aureus virulence. Virulence inhibitors could be used in the future as adjuvants to…

Continue reading